One limitation of response assessment in glioma using conventional MRI is its reliance on the measurement of contrast enhancement reflecting a disrupted blood–brain barrier. This signal may be normalized by antiangiogenic therapy, known as pseudoresponse. Amino acid PET tracers offer a more sensitive method to identify viable glioma tissue.
Original languageDanish
Title of host publicationClinical Nuclear Medicine in Neurology : An Atlas of Challenging Cases
EditorsAndrea Varrone, Silvia Morbelli, Valentina Garibotto
Number of pages3
Place of PublicationCham
PublisherSpringer International Publishing
Publication date2022
ISBN (Print)978-3-030-83598-9
Publication statusPublished - 2022

Cite this